NIH All About Grants Podcast: What Early Career Researchers Should Know (Part 1) – the Hidden Curriculum
Dr. Lauren Ullrich, co-host of Building Up the Nerve from the National Institute of Neurological Disorders and Stroke
Dr. Oliver Bogler, host of Inside Cancer Careers from the National Cancer Institute
Embarking on a career in biomedicine is more than doing experiments and writing NIH grant applications. How does one learn about other important skills early in their research career, and what exactly are they?
This episode of a two-part NIH All About Grants Podcast mini-series explores the “hidden curriculum” for early career researchers. Our conversation features hosts of two NIH podcasts that delve into topics ...
Source: NIH Extramural Nexus - September 8, 2023 Category: Research Authors: NIH Staff Tags: New Resources mentorship podcast workforce Source Type: funding
Notice of Change to Appendix Materials for PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)"
Notice NOT-NS-23-110 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 7, 2023 Category: Research Source Type: funding
Notice of Change to Award Project Period for PAR-21-153 NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)
Notice NOT-NS-23-108 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2023 Category: Research Source Type: funding
Notice of Change to Award Project Period for PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Notice NOT-NS-23-107 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 5, 2023 Category: Research Source Type: funding
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
Funding Opportunity RFA-MH-24-190 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-21-205 to comply with DMS Policy. This Notice of Funding Opportunity (NOFO), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, is one of several NOFOs aimed at supporting transformative discoveries that will lead to breakthroughs in understanding human brain function. Guided by the long-term scientific plan, BRAIN 2025: A Scientific Vision, this NOFO specifically seeks to support efforts addressing core ethical issues associated with research focused on the human brain an...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 1, 2023 Category: Research Source Type: funding
Notice of Informational Webinar for RFA-NS-24-006 and RFA-NS-24-007 "Community-Engaged Health Equity Research in Neuroscience Initiative" Notices of Funding Opportunity (R01 and R34)
Notice NOT-NS-23-109 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-25-145 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity announcement (NOFO) supports systematic and scalable approaches to profile the biological function of genes with an excess of damaging mutations in patients with neurodevelopmental and psychiatric disorders. Current understanding of the relationship between genetic and phenotypic variation is limited and one of the main bottlenecks in translating disease-associated genes to biology lies in the lack of scalable experimental platforms that can extend the unbiased nature of gene discovery to the discovery of bi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 30, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)
Notice NOT-NS-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2023 Category: Research Source Type: funding
Biotypes of CNS Complications in People Living with HIV (P01 Clinical Trial Not Allowed)
Funding Opportunity RFA-MH-24-235 from the NIH Guide for Grants and Contracts. HIV associated CNS complications are a significant problem for people living with HIV despite suppressive anti-retroviral therapy. HIV enters the CNS as early as 8 days after infection and can cause several complications including cognitive, neurological and mental health related issues. Although experts have gathered much data on underlying HIV-induced CNS pathophysiology, specific targeted causality remains elusive, and no effective therapies exist to slow, stop, or reverse these adverse outcomes. This initiative is to comprehend the action...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 29, 2023 Category: Research Source Type: funding
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-24-027 from the NIH Guide for Grants and Contracts. This notice of funding opportunity (NOFO) promotes collaborative research programs to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer's disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa. Specifically, the National Institute on Aging (NIA) seeks to support Phase Innovation Awards Cooperative Agreement (UG3/UH3) projects to enable: (1) the formation of transformative collaborations between institutions/scienti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2023 Category: Research Source Type: funding
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Funding Opportunity PAR-23-274 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD). Candidate interventions evaluated through this program, which can include small molecules or biologics for example, must engage non-amyloid/non-tau mechanisms and aim to address cognitive and/or neuropsyc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Notice of Change in Eligibility to Part I for RFA-DK-23-001 "A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)"
Notice NOT-DK-23-030 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 22, 2023 Category: Research Source Type: funding
NIH All About Grants Podcast: Reporting on Your Scientific Progress
Tom Cheever, Program Officer, National Institute of Neurological Disorders and Stroke, NIH
As part of proper stewardship and transparency, recipients must periodically tell NIH about their research progress outcomes and accomplishments when receiving an award (see NIH Grants Policy Statement Section 8.4.1 for policy and regulatory references). What exactly should someone report on and when though?
Dr. Tom Cheever, a program officer with the National Institute of Neurological Disorders and Stroke, explains more about progress reporting in this episode of the NIH All About Grants podcast. Join us as we discuss what the ...
Source: NIH Extramural Nexus - August 18, 2023 Category: Research Authors: NIH Staff Tags: New Resources Grants policy podcast RPPR Source Type: funding
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
The objective is to move devices to their next step in the FDA approval process, with the ultimate goal of generating new, FDA approved device-based treatments for SUDs. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 18, 2023 Category: Research Source Type: funding
Notice of Change in Eligibility to Section III for RFA-DK-22-036 "A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)"
Notice NOT-DK-23-031 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 17, 2023 Category: Research Source Type: funding
